Rasmus Lundquist
Founder at Reapplix A/S
Profile
Rasmus Lundquist is the founder.
He founded Reapplix A in 2008 and holds the title of Chief Scientific Officer.
He also founded Ram Biotech ApS in 2001 and holds the title of Director.
Mr. Lundquist's former job was as a Research Scientist at the University of Copenhagen.
Rasmus Lundquist active positions
Companies | Position | Start |
---|---|---|
Reapplix A/S
Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark. | Founder | 16/03/2010 |
Ram Biotech ApS
Ram Biotech ApS Medical SpecialtiesHealth Technology Ram Biotech ApS is a Danish company that researches and develops therapeutical anti-malaria antibodies. The private company is based in Copenhagen, Denmark. The company was founded by Rasmus Lundquist. | Founder | 31/12/2000 |
Former positions of Rasmus Lundquist
Companies | Position | End |
---|---|---|
University of Copenhagen | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Reapplix A/S
Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark. | Distribution Services |
Ram Biotech ApS
Ram Biotech ApS Medical SpecialtiesHealth Technology Ram Biotech ApS is a Danish company that researches and develops therapeutical anti-malaria antibodies. The private company is based in Copenhagen, Denmark. The company was founded by Rasmus Lundquist. | Health Technology |
- Stock Market
- Insiders
- Rasmus Lundquist